Dr Ronald Vandegriff, DO | |
23 Pennwood Dr, Morgantown, PA 19543-8821 | |
(610) 286-0466 | |
Not Available |
Full Name | Dr Ronald Vandegriff |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 23 Pennwood Dr, Morgantown, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275670499 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OS-010255-L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ronald Vandegriff, DO 23 Pennwood Dr, Morgantown, PA 19543-8821 Ph: (610) 286-0466 | Dr Ronald Vandegriff, DO 23 Pennwood Dr, Morgantown, PA 19543-8821 Ph: (610) 286-0466 |
News Archive
Genentech, Inc. has announced that both study arms of a randomized, multi-center Phase II clinical study of Avastin (bevacizumab) administered alone or in combination with irinotecan chemotherapy demonstrated encouraging six-month progression-free survival (PFS) and objective response rate in patients with relapsed glioblastoma multiforme (GBM), the most common and aggressive type of brain cancer.
Conventional wisdom has long blamed age-related hearing loss almost entirely on the death of sensory hair cells in the inner ear, but research from neuroscientists at Johns Hopkins has provided new information about the workings of nerve cells that suggests otherwise.
Instructions for state Medicaid directors to distribute some of the funding for electronic medical records through their programs beginning next year have been circulated by the federal Centers for Medicare & Medicaid Services, American Medical News reports. "The incentive program stipulates that the federal government will pay the full cost of Medicaid bonuses to eligible physicians who adopt certified EMR technology in a way that meets the government's 'meaningful use' criteria.
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the use of medications to treat high blood pressure affect outcomes among patients who are prescribed the medication and hospitalized with COVID-19.
Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards.
› Verified 1 days ago